Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 6.67
(2.93%)
CNY 6.67
(2.93%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 70.75 Million CNY | 109.6% |
| 2022 | 33.75 Million CNY | -10.26% |
| 2021 | 37.61 Million CNY | 367.74% |
| 2020 | 8.04 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | -100.0% |
| 2015 | 50 Million CNY | 0.0% |
| 2014 | - CNY | -100.0% |
| 2013 | 69 Million CNY | -13.75% |
| 2012 | 80 Million CNY | 1500.0% |
| 2011 | 5 Million CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 96.92 Million CNY | 0.0% |
| 2024 Q1 | 68.07 Million CNY | -0.11% |
| 2024 Q2 | 125.26 Million CNY | 161.75% |
| 2023 Q1 | 34.56 Million CNY | 2.39% |
| 2023 Q4 | 70.75 Million CNY | 15.39% |
| 2023 FY | 70.75 Million CNY | 109.6% |
| 2023 Q3 | 61.31 Million CNY | -1.88% |
| 2023 Q2 | 62.49 Million CNY | 80.8% |
| 2022 Q4 | 33.75 Million CNY | 4.39% |
| 2022 Q3 | 32.33 Million CNY | -6.29% |
| 2022 Q2 | 34.5 Million CNY | -4.09% |
| 2022 Q1 | 35.97 Million CNY | -4.35% |
| 2022 FY | 33.75 Million CNY | -10.26% |
| 2021 Q4 | 37.61 Million CNY | 1567.01% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 37.61 Million CNY | 367.74% |
| 2021 Q2 | 3 Million CNY | 0.0% |
| 2021 Q3 | 2.25 Million CNY | -24.93% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 8.04 Million CNY | 0.0% |
| 2020 Q4 | 8.04 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2016 Q1 | 130 Million CNY | 160.0% |
| 2016 Q2 | 130 Million CNY | 0.0% |
| 2016 Q4 | - CNY | -100.0% |
| 2016 Q3 | 130 Million CNY | 0.0% |
| 2016 FY | - CNY | -100.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 50 Million CNY | 0.0% |
| 2015 Q4 | 50 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2014 Q2 | 69 Million CNY | 0.0% |
| 2014 Q1 | 69 Million CNY | 0.0% |
| 2014 FY | - CNY | -100.0% |
| 2014 Q4 | - CNY | -100.0% |
| 2014 Q3 | 13.3 Million CNY | -80.72% |
| 2013 Q4 | 69 Million CNY | 0.0% |
| 2013 FY | 69 Million CNY | -13.75% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | 80 Million CNY | 1500.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 FY | 5 Million CNY | 0.0% |
| 2011 Q4 | 5 Million CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |